Intergenerational Transmission of Low-calorie Sweeteners Via Breast Milk

Sponsor
George Washington University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05379270
Collaborator
(none)
40
1
1
17
2.4

Study Details

Study Description

Brief Summary

This project aims to measure the widely consumed low-calorie sweeteners (LCS) sucralose and acesulfame-potassium, in maternal breast milk and plasma at pre-specified timepoints over 72 hours and in a single sample of infants' plasma. Sucralose and acesulfame-potassium concentrations will be measured using liquid chromatography-mass spectrometry (LC-MS). The data generated will inform the design of larger, longer-term, prospective studies needed to investigate clinically-relevant consequences of early life LCS exposure in humans.

Condition or Disease Intervention/Treatment Phase
  • Other: Diet soda
N/A

Detailed Description

Low-calorie sweetener (LCS) consumption is highly prevalent among lactating women, yet the current understanding of LCS effects on diet, weight, and health is extremely limited, especially when exposure begins early in life. This project aims to measure the widely consumed LCSs, sucralose and acesulfame-potassium, in maternal breast milk and plasma, at pre-specified, time-points over the course of 72 hours, and in a single sample of infants' plasma (analyzed using a population pharmacokinetics approach).

Mothers will attend an enrollment visit, which will take place virtually and will schedule an in-person visit to take place at Children's National Hospital approximately one week later. During the enrollment visit, informed consent will be obtained and demographic, anthropometric, and dietary data will be collected. During the week prior to their scheduled in-person study visit, mothers will be instructed to continue their usual dietary habits and to complete an online, photo-assisted, 7-day food record.

Mothers will be instructed to arrive fasted for the in-person visit, which will last for approximately 13 hours. Following ingestion of a diet beverage containing sucralose and ace-K, mothers will remain at Children's National for supervised serial sample collection at pre-determined time points over 12 hours, and will provide additional samples on three subsequent consecutive days (72 hours). Mothers will be instructed to continue to complete the online, photo-assisted, food record for the three days following the in-person study visit (until 72 hours following diet beverage consumption).

A plasma sample will be collected from each infant via heel-stick at one of the following pre-specified time intervals following the mother's ingestion of the diet beverage: 1.5-3 hours, 3-5 hours, 5-7 hours, 7-9 hours, 9-14 hours, and 22-36 hours.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Intergenerational Transmission of Low-calorie Sweeteners Via Breast Milk
Actual Study Start Date :
Feb 28, 2022
Anticipated Primary Completion Date :
Jul 31, 2023
Anticipated Study Completion Date :
Jul 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Diet soda

Participants will be asked to ingest 24 of a commercially-available diet beverage sweetened with sucralose and acesulfame-potassium.

Other: Diet soda
Participants will be asked to drink 24 ounces of a commercially-available diet beverage sweetened with sucralose and acesulfame-potassium.

Outcome Measures

Primary Outcome Measures

  1. Baseline sucralose concentrations in breast milk [baseline (pre-diet beverage)]

    Sucralose will be measured in breast milk

  2. 1-hour sucralose concentrations in breast milk [1 hour after diet beverage ingestion]

    Sucralose will be measured in breast milk

  3. 2-hour sucralose concentrations in breast milk [2 hours after diet beverage ingestion]

    Sucralose will be measured in breast milk

  4. 3-hour sucralose concentrations in breast milk [3 hours after diet beverage ingestion]

    Sucralose will be measured in breast milk

  5. 4-hour sucralose concentrations in breast milk [4 hours after diet beverage ingestion]

    Sucralose will be measured in breast milk

  6. 6-hour sucralose concentrations in breast milk [6 hours after diet beverage ingestion]

    Sucralose will be measured in breast milk

  7. 8-hour sucralose concentrations in breast milk [8 hours after diet beverage ingestion]

    Sucralose will be measured in breast milk

  8. 12-hour sucralose concentrations in breast milk [12 hours after diet beverage ingestion]

    Sucralose will be measured in breast milk

  9. 24-hour sucralose concentrations in breast milk [24 hours after diet beverage ingestion]

    Sucralose will be measured in breast milk

  10. Baseline acesulfame-potassium concentrations in breast milk [Baseline (prior to diet beverage ingestion)]

    Acesulfame-potassium will be measured in breast milk

  11. 1-hour acesulfame-potassium concentrations in breast milk [1 hour after diet beverage ingestion]

    Acesulfame-potassium will be measured in breast milk

  12. 2-hour acesulfame-potassium concentrations in breast milk [2 hours after diet beverage ingestion]

    Acesulfame-potassium will be measured in breast milk

  13. 3-hour acesulfame-potassium concentrations in breast milk [3 hours after diet beverage ingestion]

    Acesulfame-potassium will be measured in breast milk

  14. 4-hour acesulfame-potassium concentrations in breast milk [4 hours after diet beverage ingestion]

    Acesulfame-potassium will be measured in breast milk

  15. 6-hour acesulfame-potassium concentrations in breast milk [6 hours after diet beverage ingestion]

    Acesulfame-potassium will be measured in breast milk

  16. 8-hour acesulfame-potassium concentrations in breast milk [8 hours after diet beverage ingestion]

    Acesulfame-potassium will be measured in breast milk

  17. 12-hour acesulfame-potassium concentrations in breast milk [12 hours after diet beverage ingestion]

    Acesulfame-potassium will be measured in breast milk

  18. 24-hour acesulfame-potassium concentrations in breast milk [24 hours after diet beverage ingestion]

    Acesulfame-potassium will be measured in breast milk

  19. Baseline sucralose concentration in maternal plasma [baseline (before diet beverage ingestion)]

    Sucralose concentrations will be measured in maternal plasma

  20. 30-min sucralose concentration in maternal plasma [30 minutes after diet beverage ingestion]

    Sucralose concentrations will be measured in maternal plasma

  21. 1 hour sucralose concentration in maternal plasma [1 hour after diet beverage ingestion]

    Sucralose concentrations will be measured in maternal plasma

  22. 1.5 hour sucralose concentration in maternal plasma [1.5 hours after diet beverage ingestion]

    Sucralose concentrations will be measured in maternal plasma

  23. 2 hour sucralose concentration in maternal plasma [2 hours after diet beverage ingestion]

    Sucralose concentrations will be measured in maternal plasma

  24. 3 hour sucralose concentration in maternal plasma [3 hours after diet beverage ingestion]

    Sucralose concentrations will be measured in maternal plasma

  25. 4 hour sucralose concentration in maternal plasma [4 hours after diet beverage ingestion]

    Sucralose concentrations will be measured in maternal plasma

  26. 6 hour sucralose concentration in maternal plasma [6 hours after diet beverage ingestion]

    Sucralose concentrations will be measured in maternal plasma

  27. 8 hour sucralose concentration in maternal plasma [8 hours after diet beverage ingestion]

    Sucralose concentrations will be measured in maternal plasma

  28. 12 hour sucralose concentration in maternal plasma [12 hours after diet beverage ingestion]

    Sucralose concentrations will be measured in maternal plasma

  29. 24 hour sucralose concentration in maternal plasma [24 hours after diet beverage ingestion]

    Sucralose concentrations will be measured in maternal plasma

  30. 48 hour sucralose concentration in maternal plasma [48 hours after diet beverage ingestion]

    Sucralose concentrations will be measured in maternal plasma

  31. 72 hour sucralose concentration in maternal plasma [72 hours after diet beverage ingestion]

    Sucralose concentrations will be measured in maternal plasma

  32. Baseline acesulfame-potassium concentrations in maternal plasma [baseline (before diet beverage ingestion)]

    Acesulfame-potassium will be measured in maternal plasma

  33. 30 min acesulfame-potassium concentrations in maternal plasma [30 minutes after diet beverage ingestion]

    Acesulfame-potassium will be measured in maternal plasma

  34. 1 hour acesulfame-potassium concentrations in maternal plasma [1 hour after diet beverage ingestion]

    Acesulfame-potassium will be measured in maternal plasma

  35. 1.5 hour acesulfame-potassium concentrations in maternal plasma [1.5 hours after diet beverage ingestion]

    Acesulfame-potassium will be measured in maternal plasma

  36. 2 hour acesulfame-potassium concentrations in maternal plasma [2 hours after diet beverage ingestion]

    Acesulfame-potassium will be measured in maternal plasma

  37. 3 hour acesulfame-potassium concentrations in maternal plasma [3 hours after diet beverage ingestion]

    Acesulfame-potassium will be measured in maternal plasma

  38. 4 hour acesulfame-potassium concentrations in maternal plasma [4 hours after diet beverage ingestion]

    Acesulfame-potassium will be measured in maternal plasma

  39. 6 hour acesulfame-potassium concentrations in maternal plasma [6 hours after diet beverage ingestion]

    Acesulfame-potassium will be measured in maternal plasma

  40. 8 hour acesulfame-potassium concentrations in maternal plasma [8 hours after diet beverage ingestion]

    Acesulfame-potassium will be measured in maternal plasma

  41. 12 hour acesulfame-potassium concentrations in maternal plasma [12 hours after diet beverage ingestion]

    Acesulfame-potassium will be measured in maternal plasma

  42. 24 hour acesulfame-potassium concentrations in maternal plasma [24 hours after diet beverage ingestion]

    Acesulfame-potassium will be measured in maternal plasma

  43. 48 hour acesulfame-potassium concentrations in maternal plasma [48 hours after diet beverage ingestion]

    Acesulfame-potassium will be measured in maternal plasma

  44. 72 hour acesulfame-potassium concentrations in maternal plasma [72 hours after diet beverage ingestion]

    Acesulfame-potassium will be measured in maternal plasma

  45. Sucralose concentrations in infant plasma [varies across infants]

    Sucralose will be measured in infant plasma at a single timepoint following ingestion of the diet beverage

  46. Acesulfame-potassium concentrations in infant plasma [varies across infants]

    Acesulfame-potassium will be measured in infant plasma at a single timepoint following ingestion of the diet beverage

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • mother gave birth within the past 6 months

  • mother ≥18 years of age

  • exclusively breastfeeding

  • reports consumption of diet, low-calorie sweetener-containing beverages ≥ 1 time per week.

  • infants' corrected age >= 4 weeks

Exclusion Criteria:
  • known allergy or contraindication to sucralose or acesulfame-potassium (infant or mother)

  • active nutritional disorder known to cause malabsorption

Contacts and Locations

Locations

Site City State Country Postal Code
1 The George Washington University Washington District of Columbia United States 20052

Sponsors and Collaborators

  • George Washington University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
George Washington University
ClinicalTrials.gov Identifier:
NCT05379270
Other Study ID Numbers:
  • NCR213471
First Posted:
May 18, 2022
Last Update Posted:
May 18, 2022
Last Verified:
May 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by George Washington University

Study Results

No Results Posted as of May 18, 2022